Eligible providers in Florida, Georgia and South Carolina can now immediately enroll in the 340B program without waiting for the [...] …
Month: August 2024
Minnesota Gov. Tim Walz, Vice President Kamala Harris’ Democratic running mate in the U.S. presidential race, has been a vocal [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A state hospital-backed candidate won Tuesday’s Missouri Republican gubernatorial primary after defeating a high-profile opponent with dark money ties who [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Health Resources and Services Administration (HRSA) held a webinar yesterday to guide hospitals through their annual 340B recertification period, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
More than two-thirds of 340B contract pharmacies are associated with pharmacy benefit managers (PBMs) through either vertical integration or contractual [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A recent opinion piece published in JAMA is calling for significant reforms to the 340B program, including more provider transparency, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
With the annual 340B hospital recertification period occurring Aug. 12 to Sept. 9, the Health Resources and Services Administration’s (HRSA’s) [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Senate panel responsible for federal appropriations legislation overwhelmingly passed a bill last week that would increase funding for the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical manufacturers Sanofi, GlaxoSmithKline (GSK) and Viatris are fully or partially exempting additional states from their 340B contract pharmacy restrictions. [...] …
